Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04447313 · ClinicalTrials.gov registry record · Phase 3
Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study
A Phase 3 study of Obesity-Related Malignant Neoplasm, sponsored by Fred Hutchinson Cancer Center.
- Active
- Registry status
- Phase 3
- Development phase
- 418
- Enrollment target
- 1
- Study location
NCT04447313: Active Phase 3 study of Obesity-Related Malignant Neoplasm, sponsored by Fred Hutchinson Cancer Center.
NCT04447313 is a Phase 3 study of Obesity-Related Malignant Neoplasm that is active but no longer recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 418 participants, above the 189-participant average among 6 other Obesity-Related Malignant Neoplasm trials with a reported enrollment target (121% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04447313, a Phase 3 study of Obesity-Related Malignant Neoplasm, is active but no longer recruiting, sponsored by Fred Hutchinson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 418 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase III trial compares telephone delivered Acceptance and Commitment Therapy to standard behavioral therapy for improving weight loss in overweight or obese participants. Acceptance and Commitment Therapy focuses on increasing willingness to experience physical cravings, emotions, and thoughts while making values-guided committed behavior changes. Acceptance and Commitment Therapy may work better at improving weight loss compared to standard behavioral therapy.
Primary Outcome
Will be measured remotely by cellular-enabled scales. Will compare the two telephone interventions, using logistic regression.
Conditions Studied
Interventions
- OTHER Survey Administration
- BEHAVIORAL Telephone-Based Intervention
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 418 participants |
| Start Date | 2021-03-05 |
| Est. Completion | 2026-11-09 |
| Phase | Phase 3 |
What the registry record for NCT04447313 still lists
NCT04447313 is an interventional study that assigns participants to a tested intervention. The registered 418 participants enrollment target is mid-sized for trials with a published cap, above the 189-participant average among 6 other Obesity-Related Malignant Neoplasm trials with a reported enrollment target (121% higher).
The record links to 1 condition, with Obesity-Related Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Survey Administration is the first listed.
NCT04447313 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04447313 about?
NCT04447313 is a clinical study titled "Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study". This phase III trial compares telephone delivered Acceptance and Commitment Therapy to standard behavioral therapy for improving weight loss in overweight or obese participants. Acceptance and Commitment Therapy focuses on increasing willingness to experience physical cravings, emotions, and thought...
What is the current status of trial NCT04447313?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 418 participants. The study started on 2021-03-05. Estimated completion is 2026-11-09.
What conditions does trial NCT04447313 study?
This clinical trial studies the following conditions: Obesity-Related Malignant Neoplasm.
What interventions are being tested in trial NCT04447313?
The interventions under investigation include: Survey Administration (OTHER), Telephone-Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04447313?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04447313 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity-Related Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants
RECRUITING
-
Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women
RECRUITING · NA
-
Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American Families
ACTIVE NOT RECRUITING · NA
-
Parent and Family Obesity Intervention in Reducing Obesity Risk in Racial Ethnic Minority Families
ACTIVE NOT RECRUITING · NA
-
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
ACTIVE NOT RECRUITING · NA
-
Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03135886 · 418 participants · NA
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT06169735 · 417 participants · Phase 4
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
- NCT06699901 · 417 participants
Antibiotic Concentrations After MassivE Transfusion Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI